The share of adults who have a will should be 100%, but it hovers consistently at 30% in the U.S. There's no reason for this.
MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback